This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Prebiotic Effect on Metabolites in Crohn's Disease

This study has been completed.
Information provided by (Responsible Party):
Kristin Verbeke, Katholieke Universiteit Leuven Identifier:
First received: December 6, 2011
Last updated: December 9, 2011
Last verified: December 2011
The purpose of this study is to investigate the influence of the prebiotic oligofructose enriched inulin on the metabolite pattern in Crohn's disease patients.

Condition Intervention
Crohn Disease Dietary Supplement: Oligofructose enriched inulin Dietary Supplement: Maltodextrin

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Basic Science
Official Title: Metabolite Profiling of the Impact of Oligofructose Enriched Inulin in Crohn's Disease Patients

Resource links provided by NLM:

Further study details as provided by Kristin Verbeke, Katholieke Universiteit Leuven:

Enrollment: 67
Study Start Date: March 2008
Estimated Study Completion Date: July 2009
Arms Assigned Interventions
Active Comparator: Prebiotic Dietary Supplement: Oligofructose enriched inulin
Placebo Comparator: Placebo Dietary Supplement: Maltodextrin


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • crohn's disease

Exclusion Criteria:

  • severe crohn's disease (harvey bradshaw index >12)
  • pregnancy
  • history of colectomy
  • use of antibiotics 4-wks before start of the study
  • use of sulfapyridine
  • use of commercially available prebiotics and probiotics
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01487759

Leuven, Belgium, 3000
Sponsors and Collaborators
Katholieke Universiteit Leuven
  More Information

Responsible Party: Kristin Verbeke, Principal investigator, Katholieke Universiteit Leuven Identifier: NCT01487759     History of Changes
Other Study ID Numbers: ML4789
Study First Received: December 6, 2011
Last Updated: December 9, 2011

Additional relevant MeSH terms:
Crohn Disease
Inflammatory Bowel Diseases
Gastrointestinal Diseases
Digestive System Diseases
Intestinal Diseases processed this record on September 19, 2017